Bill Snyder

Communication and collaboration were major themes of the inaugural Research Enterprise Forum sponsored jointly by Vanderbilt University Medical Center (VUMC) and Vanderbilt University School of Medicine (VUSM) Feb. 3 in Light Hall.

Researchers at Vanderbilt University Medical Center (VUMC) have taken another step toward developing a vaccine against respiratory syncytial virus (RSV), the major cause of life-threatening pneumonia in infants worldwide.

Researchers at Vanderbilt have identified what may be a genetic “smoking gun” for autism spectrum disorder (ASD) — a mutation in the gene for the critical neuronal protein CaMKII.

Vanderbilt University Medical Center (VUMC) makes this promise to patients and their families: to include them as a member of the health care team, respect their privacy, coordinate and personalize their care, communicate clearly and serve them with kindness and respect. Delivering on that promise was the theme of Wednesday’s Winter Leadership Assembly in Langford Auditorium.

As a fellow in pulmonary and critical care medicine at Vanderbilt University School of Medicine, Bradley Richmond, M.D., saw a lot of patients with chronic obstructive pulmonary disease (COPD), an inflammatory lung disease caused most often by long-term exposure to cigarette smoke.

This month the Office of Research at Vanderbilt University Medical Center (VUMC) began transitioning VUMC research cores, facilities and shared resources (known collectively as “cores”) to a new core management application that officials said will streamline ordering and billing for core services.